Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Heilig

Showing results (131-140 of 313) with videos related to

Pageof 32
Sort By:
Biological Psychiatry|December 9, 2008
Suppressed neuroendocrine stress response in depressed women on job-stress-related long-term sick leave: a stable marker potentially suggestive of preexisting vulnerabilityKristina Wahlberg, Per Hamid Ghatan, Sieglinde Modell, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|December 24, 2023
Contributions of Polygenic Risk and Disease Status to Gray Matter Abnormalities in Major DepressionRobin Kämpe, Elisabeth R Paul, Lars Östman, et al.
The International Journal on Drug Policy|January 3, 2026
Challenges in managing driving licence legislation when using B-Phosphatidylethanol to identify high levels of alcohol use in primary care patients: A qualitative studyÅsa Steensland, Lisa Kastbom, Björn Johnson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 23, 2021
Addiction as a brain disease revised: why it still matters, and the need for consilienceMarkus Heilig, James MacKillop, Diana Martinez, et al.
Biological Psychiatry|September 14, 2007
Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependenceJohan Kakko, Joachim von Wachenfeldt, Kerstin Dybrandt Svanborg, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 17, 2008
Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophreniaRose-Marie Karlsson, Kohichi Tanaka, Lisa M Saksida, et al.
Biology of Sex Differences|February 17, 2024
Different mechanisms underlie compulsive alcohol self-administration in male and female ratsSanne Toivainen, Li Xu, Francesco Gobbo, et al.
Pharmacology, Biochemistry, and Behavior|March 23, 2011
Exposure to nicotine during periadolescence or early adulthood alters aversive and physiological effects induced by ethanolJennifer A Rinker, Mary Anne Hutchison, Scott A Chen, et al.
Molecular Psychiatry|April 7, 2021
Re-examining the link between childhood maltreatment and substance use disorder: a prospective, genetically informative studyAndrea J Capusan, Per A Gustafsson, Ralf Kuja-Halkola, et al.
Psychopharmacology|May 24, 2020
PPARγ activation by pioglitazone does not suppress cravings for alcohol, and is associated with a risk of myopathy in treatment seeking alcohol dependent patients: a randomized controlled proof of principle studyMelanie L Schwandt, Nancy Diazgranados, John C Umhau, et al.
Pageof 32

Showing results (131-140 of 313) with videos related to

Sort By:
Pageof 32
Biological Psychiatry|December 9, 2008
Suppressed neuroendocrine stress response in depressed women on job-stress-related long-term sick leave: a stable marker potentially suggestive of preexisting vulnerabilityKristina Wahlberg, Per Hamid Ghatan, Sieglinde Modell, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|December 24, 2023
Contributions of Polygenic Risk and Disease Status to Gray Matter Abnormalities in Major DepressionRobin Kämpe, Elisabeth R Paul, Lars Östman, et al.
The International Journal on Drug Policy|January 3, 2026
Challenges in managing driving licence legislation when using B-Phosphatidylethanol to identify high levels of alcohol use in primary care patients: A qualitative studyÅsa Steensland, Lisa Kastbom, Björn Johnson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 23, 2021
Addiction as a brain disease revised: why it still matters, and the need for consilienceMarkus Heilig, James MacKillop, Diana Martinez, et al.
Biological Psychiatry|September 14, 2007
Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependenceJohan Kakko, Joachim von Wachenfeldt, Kerstin Dybrandt Svanborg, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 17, 2008
Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophreniaRose-Marie Karlsson, Kohichi Tanaka, Lisa M Saksida, et al.
Biology of Sex Differences|February 17, 2024
Different mechanisms underlie compulsive alcohol self-administration in male and female ratsSanne Toivainen, Li Xu, Francesco Gobbo, et al.
Pharmacology, Biochemistry, and Behavior|March 23, 2011
Exposure to nicotine during periadolescence or early adulthood alters aversive and physiological effects induced by ethanolJennifer A Rinker, Mary Anne Hutchison, Scott A Chen, et al.
Molecular Psychiatry|April 7, 2021
Re-examining the link between childhood maltreatment and substance use disorder: a prospective, genetically informative studyAndrea J Capusan, Per A Gustafsson, Ralf Kuja-Halkola, et al.
Psychopharmacology|May 24, 2020
PPARγ activation by pioglitazone does not suppress cravings for alcohol, and is associated with a risk of myopathy in treatment seeking alcohol dependent patients: a randomized controlled proof of principle studyMelanie L Schwandt, Nancy Diazgranados, John C Umhau, et al.
Pageof 32